Featured Research

from universities, journals, and other organizations

Protein That May Be 'Boon' To Medicine Isolated

Date:
August 6, 2009
Source:
University of California - Santa Barbara
Summary:
Scientists have isolated a unique protein that appears to have a dual function and could lead to a "boon in medicine."

Scientists at UC Santa Barbara have isolated a unique protein that appears to have a dual function and could lead to a "boon in medicine." The findings are published in the August issue of the Journal of Cell Biology.

The protein that the researchers studied, named mDpy-30, affects both the expression of genes and the transport of proteins. "We first found that this protein has a dual location in the cell," said Dzwokai Ma, senior author and assistant professor in UCSB's Department of Molecular, Cellular and Developmental Biology. "That spurred us to investigate this protein further, because location is always linked to function."

Proteins that are most sensitive to mDpy-30 are pivotal to the movement of a cell, according to the current study and unpublished results from the Ma lab. "Indeed, we have obtained preliminary evidence that mDpy-30 is an important regulator of cell movement," said Ma. "The movement of a cell is essential to myriad biological functions such as neural networking, proper immunological function, and wound healing. Consequently, when these processes go awry, they can result in the development or progression of human disease, including cancer metastasis."

What remains enigmatic, Ma added, is the particular role of mDpy-30 in protein transport regulation, and whether or how this function is coordinated with gene expression during cell movement. "Further study could lead to a boon in medicine," he said.

First authors from UCSB who contributed equally to the paper, are: Zhuojin Xu, Qiang Gong, and Bin Xia. Additional co-authors are Benjamin Groves, Mark Zimmerman, Brian Matsumoto, and Chris Mugler, of UCSB; Dezhi Mu of Sichuan University, Chengdu, China; and Matthew Seaman of the University of Cambridge, Cambridge, U.K.


Story Source:

The above story is based on materials provided by University of California - Santa Barbara. Note: Materials may be edited for content and length.


Cite This Page:

University of California - Santa Barbara. "Protein That May Be 'Boon' To Medicine Isolated." ScienceDaily. ScienceDaily, 6 August 2009. <www.sciencedaily.com/releases/2009/08/090805084955.htm>.
University of California - Santa Barbara. (2009, August 6). Protein That May Be 'Boon' To Medicine Isolated. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/08/090805084955.htm
University of California - Santa Barbara. "Protein That May Be 'Boon' To Medicine Isolated." ScienceDaily. www.sciencedaily.com/releases/2009/08/090805084955.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins